Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Sinclair Declares $0.25 Per Share Quarterly Cash Dividend
-
Alto Ingredients, Inc. Reports Third Quarter 2026 Results
-
PacBio Announces Third Quarter 2026 Financial Results
-
Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance
-
Clover Health Reports Third Quarter 2026 Results
-
Runway Growth Finance Corp. Announces Fourth Quarter 2026 Dividend of $0.33 per Share
-
Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
-
Larimar Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
-
Interparfums, Inc. Reports 2026 Third Quarter and Nine-Month Results; Raises Full Year Sales Guidance and Reaffirms Earnings Outlook
-
Mineralys Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
-
Cytek Biosciences Reports Third Quarter 2026 Financial Results
-
electroCore Announces Third Quarter 2026 Financial Results
-
OnKure Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights
-
Medicus Pharma to Host Third Quarter 2026 Financial Performance and Business Update Call on November 9, 2026
-
BillionToOne Reports Third Quarter 2026 Results and Raises 2026 Revenue Guidance
-
Nature's Sunshine Reports Third Quarter 2026 Results
-
Pennant Reports Third Quarter 2026 Results
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2026
-
Matrix Service Company Reports Fiscal Year 2027 First Quarter Results
-
Alamar Biosciences to Participate in Upcoming Investor Conferences
-
Polar Power Clarifies Roth Equity Facility Activity; Confirms No Company Sales Since October 19
-
Kailera Reports Third Quarter 2026 Financial Results and Provides Business Updates
-
Rapid7 Announces Third Quarter 2026 Financial Results
-
Magnite Reports Third Quarter 2026 Results
-
XBP Global Schedules Conference Call for Third Quarter 2026 Financial Results
-
Myriad Genetics Reports Third Quarter 2026 Financial Results; Raises Mid-Point of Full-Year 2026 Revenue Guidance Following Solid Execution Definitive Agreement to Sell Prenatal Health Business to Sup
-
Ormat Technologies Reports Third Quarter 2026 Financial Results
-
Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results
-
Vaxcyte Reports Third Quarter 2026 Financial Results and Provides Business Update
-
PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
-
Remitly Reports Record Third Quarter Results and Raises Full Year 2026 Outlook
-
BBSI Reports Third Quarter 2026 Financial Results
-
Encore Capital Group Announces Third Quarter 2026 Financial Results
-
Veracyte Announces Third Quarter 2026 Financial Results
-
Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates
-
ThredUp Announces Third Quarter 2026 Results
-
Gold.com Reports Fiscal First Quarter 2027 Results
-
Nasdaq Reports October 2026 Volumes
-
ADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update
-
red violet Reports Third Quarter 2026 Financial Results
-
Interparfums, Inc. Reports 2026 Third Quarter and Nine-Month Results; Raises Full Year Sales Guidance and Reaffirms Earnings Outlook
-
Lesaka Delivers Q1 FY2027 Results in Line with Expectations, Reaffirms FY2027 Guidance
-
Silvaco Reports Third Quarter 2026 Financial Results
-
Robinhood Markets, Inc. to Present at the Wolfe Research Wealth Symposium on November 11, 2026
-
Coherent Corp. Reports First Quarter Fiscal 2027 Results
-
EverQuote to Present at Upcoming Investor Conferences
-
Immuneering to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
-
Agomab to Participate in Upcoming Investor Conferences
-
Vertex Announces Third Quarter 2026 Financial Results
-
Green Thumb Industries Reports Third Quarter 2026 Results


